Companies Cryptocurrencies
BioNTech SE
BioNTech SE
Exchange: NasdaqGS
IPO Date: 10/10/2019
CEO: Prof. Ugur Sahin M.D.
Biotechnology Healthcare 🔗
  • BNTX
  • 160.92
  • 39106617344
    market cap
  • 3.7099915
If you bought

shares of BioNTech SE (BNTX) on
You would have made
Old Price $12 Current Price $12

BioNTech SE operates as a clinical-stage biotechnology company. The company is headquartered in Mainz, Rheinland-Pfalz and currently employs 1,179 full-time employees. The firm focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The company develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company offers diagnostic products and drug discovery services for other therapeutic areas, including infectious diseases, allergies and autoimmune disorders.

Address: An der Goldgrube 12 Mainz RHEINLAND-PFALZ 55131

Stay updated.